Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
April 24, 2025
Rare Diseases Weekly News – April 24th 2025
April 24, 2025
Cell and Gene Therapy Weekly News – April 24th 2025
April 24, 2025
Cardiovascular Weekly News – April 24th 2025
April 23, 2025
Immunology Weekly News – April 23rd 2025
April 23, 2025
Neuroscience Weekly News – April 23rd 2025
April 22, 2025
Endocrinology Weekly Update – 22nd April 2025
April 22, 2025
Obesity Weekly News – April 22nd 2025
April 21, 2025
Oncology Weekly News – April 21st 2025
April 21, 2025
Hematology Weekly News – April 21st 2025
April 21, 2025
Artificial Intelligence and Digital Health Weekly News – April 21st 2025
April 18, 2025
Public Health Weekly News -18th April 2025
April 18, 2025